US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 62.360
  • +0.070+0.11%
Close Feb 14 16:00 ET
  • 62.360
  • 0.0000.00%
Post 17:01 ET
3.13BMarket Cap24.55P/E (TTM)

Haemonetics Key Stats

Haemonetics Q3 2025 Earnings Date

Currency:USDFeb 6, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
352.88M
348.54M
-4.34M
Miss Est.
+4.95%
+3.66%
-1.23%
EPS
0.91
0.74
-0.17
Miss Est.
+48.75%
+21.31%
-18.45%
Strong Buy

Feb 7, 2025

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 319.161M--
--2025/Q4-- / 330.634M--
Feb 6, 20252025/Q3348.542M / 352.883M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 319.161M--
--2025/Q4-- / 330.634M--
Feb 6, 20252025/Q3348.542M / 352.883M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More